I. INTRODUCTION This guidance is intended to describe the Food and Drug Administration’s( FDA’s) current thinking regarding the compass and operation of part 11 of Title 21 of the law
I. INTRODUCTION This guidance is intended to describe the Food and Drug Administration’s( FDA’s) current thinking regarding the compass and operation of part 11 of Title 21 of the law